ClinConnect ClinConnect Logo
Search / Trial NCT06298227

Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Feb 29, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Laparoscopic Nephrectomy Postoperative Pain Management Erector Spinae Plane Block Quadratus Lumborum Block

ClinConnect Summary

This clinical trial is studying two different methods of providing pain relief after a specific kidney surgery called laparoscopic nephrectomy, which involves removing a kidney using small incisions. The two methods being compared are called the Erector Spinae Plane Block (ESPB) and the Quadratus Lumborum Block (QLB). Both techniques involve injecting a local anesthetic to help reduce pain after surgery, but they do so in slightly different ways. The goal is to see which method works better for controlling pain after the procedure.

To be eligible for this trial, participants should be between the ages of 18 and 75, scheduled for a living donor laparoscopic nephrectomy, and classified as having low to moderate health risks. However, people with certain conditions, such as bleeding disorders, allergies to anesthetics, or who are pregnant, cannot participate. Those who join the trial can expect to receive either the ESPB or QLB before their surgery and will be monitored for how well each method helps with pain management afterwards. This research aims to improve pain relief options for patients undergoing this type of kidney surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • American Society of Anesthesiologists (ASA) classification I-II
  • Scheduled for living donor laparoscopic nephrectomy under general anesthesia
  • Exclusion Criteria:
  • history of bleeding diathesis,
  • receiving anticoagulant treatment,
  • known local anesthetics and opioid allergy,
  • infection of the skin at the site of the needle puncture,
  • pregnancy or lactation,
  • patients who refuse the procedure or participation in the study

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, Bağcılar, Turkey

Istanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported